Stryker shares are trading lower after the company reported Q2 financial results and announced it anticipates a moderately unfavorable impact on FY24 net sales guidance. Also, it expects to be negatively impacted in its adjusted net EPS guidance.
Portfolio Pulse from Benzinga Newsdesk
Stryker shares are trading lower after the company reported Q2 financial results and announced it anticipates a moderately unfavorable impact on FY24 net sales guidance. Additionally, it expects a negative impact on its adjusted net EPS guidance.
July 30, 2024 | 8:29 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Stryker shares are trading lower following the release of Q2 financial results. The company anticipates a moderately unfavorable impact on FY24 net sales guidance and expects a negative impact on its adjusted net EPS guidance.
The announcement of a moderately unfavorable impact on FY24 net sales guidance and a negative impact on adjusted net EPS guidance is likely to concern investors, leading to a short-term decline in Stryker's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100